Invention Grant
- Patent Title: Spiro azetidine isoxazole derivatives and their use as SSTR antagonists
-
Application No.: US14775265Application Date: 2014-03-13
-
Publication No.: US09605000B2Publication Date: 2017-03-28
- Inventor: Shizuo Kasai , Masaki Ogino , Ryo Mizojiri , Takeshi Yamasaki , Hideki Hirose , Nobuyuki Takakura , Tohru Yamashita , Sachie Morimoto , Takashi Nakahata , Asato Kina
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Foley & Lardner LLP
- Priority: JP2013-052482 20130314
- International Application: PCT/JP2014/058144 WO 20140313
- International Announcement: WO2014/142363 WO 20140918
- Main IPC: C07D498/10
- IPC: C07D498/10 ; A61P3/00 ; A61K31/424
Abstract:
Provided is a compound represented by the following formula (1) or a salt thereof, which has an SSTR5 antagonistic action: wherein each symbol has the same definition as in the specification.
Public/Granted literature
- US20160060273A1 HETEROCYCLIC COMPOUND Public/Granted day:2016-03-03
Information query
